Evidence map›Paper›PMID 40129308›Full record

ArticleTuberculosis and respiratory diseases2025

Challenges and the Future of Pulmonary Function Testing in Chronic Obstructive Pulmonary Disease (COPD): Toward Earlier Diagnosis of COPD.

Sang Hyuk Kim, MeiLan K Han

Abstract read
In one paragraph

Article in Tuberculosis and respiratory diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. PulmoClass-3DAtt: A Self-Attention Network for Classification of COPD, PRISm and Normal.International journal of chronic obstructive pulmonary disease · 2026
    Article
  9. Beyond Reported Rates: Detection-Adjusted COPD Prevalence and Underdiagnosis Patterns in Colombia.International journal of chronic obstructive pulmonary disease · 2026
    Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sang Hyuk KimDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
MeiLan K HanDivision of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA.

Funding

Defining Pathways in COPD Patient Oriented ResearchK24HL138188 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MeiLan K Han · 2017 to 2026
$1.2M
American Lung AssociationAstraZenecaBiodesixBoehringer IngelheimCOPD FoundationGala TherapeuticsNHLBI NIH HHS K24 HL138188NIH HHSNovartisNuvairaSanofiSunovion
6 · The paper itself

Abstract

In the field of chronic obstructive pulmonary disease (COPD), there is growing interest in methods for early detection with the goal of altering disease progression. At the same time, pulmonary function test (PFT) remains central to the diagnosis and management of COPD. Yet, spirometry remains underused, particularly in primary care, contributing to the underdiagnosis and misdiagnosis of COPD. Challenges hindering more aggressive use of spirometry include a lack of access in primary care clinics or public venues, the complexity of performing spirometry and a lack of comfort with interpretation. Enhancing PFT utilization will require new approaches including broadening availability and adopting different approaches to interpretation.

Indexed as

Chronic Obstructive Pulmonary DiseasePulmonary Function TestsSpirometryUnderdiagnosis

Identifiers

PMID40129308
PMCPMC12235289

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.